This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both an amino group and a cyano group, makes it a versatile building block for the development of drugs targeting neurological and psychiatric disorders. Specifically, it is employed in the production of compounds that modulate neurotransmitter systems, such as GABAergic or glutamatergic pathways, which are critical in treating conditions like anxiety, depression, and epilepsy. Additionally, its chiral nature allows for the creation of enantiomerically pure drugs, enhancing therapeutic efficacy and reducing potential side effects. Researchers also explore its use in designing prodrugs or drug delivery systems to improve bioavailability and targeted action.